Antinephritic Effect of Prostaglandin E1 on Serum Sickness Nephritis in Rats (3) Suppression of Leukocytes by Prostaglandin Ei as a Mechanism for Preventing Immune Complex Glomerulonephritis
Open Access
- 1 January 1986
- journal article
- research article
- Published by Elsevier in The Japanese Journal of Pharmacology
- Vol. 42 (1) , 109-116
- https://doi.org/10.1254/jjp.42.109
Abstract
Serum sickness nephritis was produced in rats by repeated i.v. injections of rabbit serum albumin. After 12 weeks of antigen injection, the rats with proteinuria were subjected to a renal biopsy. Then half of the group was continuously given 300 .mu.g/rat/day of PGE1.cntdot..alpha.-cyclodextrin (PGE1.cntdot.CD) with mini osmotic pumps for 3 weeks. PGE.cntdot.CD inhibited the development of glomerulonephritis and the deposition of immune complexes in the gomeruli, although the control groups showed developed glomerular alteration and increased immune deposits in the glomeruli in the autopsy specimens. PGE1.cntdot.CD particularly improved the intraluminal hypercellularity of the histological findings. In the early stage of this model, 0.5 and 1.0 mg/kg of PGE1 and 6.0, 12.5 and 25.0 mg/kg of azathioprine were administered s.c. and p.o., respectively, for 3 weeks. There was a significant suppression of about 20% in the 1.0 mg/kg PGE1 group on the antibody synthesis as compared with the control group throughout the experimental period, although the inhibition was less than that of azathioprine. In the same experimental protocol; PGE1 significantly suppressed the increase in leukocyte counts; at the third week after PGE1, the number of leukocytes was 25.6 .+-. 4.2 .times. 103 in the control group and 14.1 .+-. 3.0 .times. 103 in the 1.0 mg/kg PGE1 group. It is considered that PGE1 could exert the antinephritic effect in this mode through decreasing the leukocyte counts in the circulation and the glomeruli independently of immune deposits in the glomeruli.This publication has 26 references indexed in Scilit:
- Treatment of murine immune complex glomerulonephritis with prostaglandin E2: Dose-response of immune complex deposition, antibody synthesis, and glomerular damageClinical Immunology and Immunopathology, 1983
- Studies on antinephritic effect of mizoribine (p-INN, bredinin), a new immunosuppressive agent, and azathioprine. (1). Effect on the nephrotic type of anti-GBM nephritis in rats.The Japanese Journal of Pharmacology, 1983
- Selective suppression of retroviral gp70-anti-gp70 immune complex formation by prostaglandin E1 in murine systemic lupus erythematosus.The Journal of Experimental Medicine, 1980
- Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus.The Journal of Experimental Medicine, 1979
- Evidence for a pathogenic role of a cell-mediated immune mechanism in experimental glomerulonephritis.The Journal of Experimental Medicine, 1978
- Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.The Journal of Experimental Medicine, 1977
- Prostaglandin e1 treatment of NZB/NZW F1 hybrid MICEArthritis & Rheumatism, 1977
- Prostaglandin E1 treatment of NZB/NZW miceArthritis & Rheumatism, 1977
- Inhibition of tumour growth in vivo and in vitro by prostaglandin ENature, 1976
- Human lymphocyte metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutininJournal of Clinical Investigation, 1971